Home › Agent Hub › Agent Tools › Part D coverage by drug › Trijardy
Agent Tools
Trijardy is a brand of empagliflozin / linagliptin / metformin. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,554 of 5,492 Medicare Part D and Medicare Advantage drug plans (64.7%) list Trijardy on their formulary, across 181 of 286 formularies. The most common placement is tier 3 (3,270 plans, 92% of those covering it). 7 of the covering plans require prior authorization (0.2%), 0 step therapy and 3,503 a quantity limit.
364 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $42, 78 of them $0; 3,190 charge coinsurance instead — median 22% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,472 of 5,496 plans covered it (81.4%); 2027: 3,554 of 5,492 (64.7%).
Of 4,367 plans offered in both years, 16 added it to the formulary and 919 dropped it.
Among plans covering it both years, 24 moved it to a higher tier and 168 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 69 |
| Tier 2 | 207 |
| Tier 3 | 3,270 |
| Tier 6 | 8 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 65 of 323 | 20.1% | 0% |
| Medicare Advantage with drugs (MA-PD) | 2,023 of 3,200 | 63.2% | 0% |
| Special needs plans (SNP) | 1,466 of 1,969 | 74.5% | 0.5% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 796 of 830 | Tier 3 | 0 |
| Devoted Health | 728 of 728 | Tier 3 | 0 |
| Aetna Medicare | 631 of 631 | Tier 3 | 0 |
| Wellcare | 200 of 268 | Tier 2 | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 80 of 80 | Tier 3 | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 3 | 0 |
| Wellpoint | 58 of 63 | Tier 3 | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 36 of 36 | Tier 3 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 1 of 27 | Tier 3 | 0 |
| Anthem HealthKeepers | 22 of 26 | Tier 3 | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 66 of 114 | 57.9% |
| Alaska | 2 of 9 | 22.2% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 109 of 147 | 74.1% |
| Arkansas | 52 of 85 | 61.2% |
| California | 240 of 397 | 60.5% |
| Colorado | 61 of 106 | 57.5% |
| Connecticut | 43 of 54 | 79.6% |
| Delaware | 29 of 43 | 67.4% |
| District of Columbia | 8 of 12 | 66.7% |
| Florida | 309 of 545 | 56.7% |
| Georgia | 78 of 149 | 52.3% |
| Guam | 1 of 1 | 100% |
| Hawaii | 32 of 50 | 64% |
| Idaho | 26 of 45 | 57.8% |
| Illinois | 90 of 132 | 68.2% |
| Indiana | 102 of 138 | 73.9% |
| Iowa | 46 of 64 | 71.9% |
| Kansas | 53 of 84 | 63.1% |
| Kentucky | 71 of 121 | 58.7% |
| Louisiana | 82 of 125 | 65.6% |
| Maine | 33 of 52 | 63.5% |
| Maryland | 23 of 49 | 46.9% |
| Massachusetts | 49 of 89 | 55.1% |
| Michigan | 65 of 182 | 35.7% |
| Minnesota | 32 of 63 | 50.8% |
| Mississippi | 64 of 104 | 61.5% |
| Missouri | 123 of 170 | 72.4% |
| Montana | 5 of 27 | 18.5% |
| Nebraska | 32 of 51 | 62.7% |
| Nevada | 66 of 100 | 66% |
| New Hampshire | 12 of 25 | 48% |
| New Jersey | 50 of 73 | 68.5% |
| New Mexico | 42 of 68 | 61.8% |
| New York | 183 of 215 | 85.1% |
| North Carolina | 115 of 176 | 65.3% |
| North Dakota | 12 of 26 | 46.2% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 117 of 171 | 68.4% |
| Oklahoma | 44 of 81 | 54.3% |
| Oregon | 60 of 92 | 65.2% |
| Pennsylvania | 240 of 323 | 74.3% |
| Puerto Rico | 62 of 64 | 96.9% |
| Rhode Island | 17 of 29 | 58.6% |
| South Carolina | 49 of 89 | 55.1% |
| South Dakota | 14 of 30 | 46.7% |
| Tennessee | 107 of 156 | 68.6% |
| Texas | 271 of 407 | 66.6% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 31 of 53 | 58.5% |
| Vermont | 3 of 14 | 21.4% |
| Virginia | 79 of 144 | 54.9% |
| Washington | 63 of 114 | 55.3% |
| West Virginia | 38 of 69 | 55.1% |
| Wisconsin | 64 of 96 | 66.7% |
| Wyoming | 1 of 13 | 7.7% |
Medicare Part D paid for 175,727 30-day fills of Trijardy in 2024 for about 21,508 enrollees, at an average total cost of $561.82 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Trijardy and the rest of a client's list on every plan in their county.
Estimate Trijardy costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.